Stone Lydia 4
4 · Evolent Health, Inc. · Filed Sep 4, 2018
Insider Transaction Report
Form 4
Stone Lydia
Principal Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2018-08-30$6.87/sh+1,000$6,870→ 16,390 total - Sale
Class A Common Stock
2018-08-30$25.00/sh−1,000$25,000→ 15,390 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2018-08-30−1,000→ 1,000 totalExercise: $6.87Exp: 2025-01-01→ Class A Common Stock (1,000 underlying) - Exercise/Conversion
Class A Common Stock Option (right to buy)
2018-08-30−1,532→ 4,595 totalExercise: $18.25Exp: 2027-02-01→ Class A Common Stock (1,532 underlying) - Exercise/Conversion
Class A Common Stock Option (right to buy)
2018-08-30−2,908→ 5,814 totalExercise: $10.27Exp: 2026-03-01→ Class A Common Stock (2,908 underlying) - Sale
Class A Common Stock
2018-08-30$25.00/sh−2,908$72,700→ 15,390 total - Sale
Class A Common Stock
2018-08-30$25.00/sh−1,532$38,300→ 15,390 total - Sale
Class A Common Stock
2018-08-30$25.00/sh−1,365$34,125→ 15,390 total - Exercise/Conversion
Class A Common Stock
2018-08-30$10.27/sh+2,908$29,865→ 18,298 total - Exercise/Conversion
Class A Common Stock
2018-08-30$18.25/sh+1,532$27,959→ 16,922 total
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2017.
- [F2]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The Class A Common Stock Options exercised vested on January 1, 2018.
- [F4]The Class A Common Stock Options exercised vested on March 1, 2018.
- [F5]The Class A Common Stock Options exercised vested on February 1, 2018.